Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark. more
Time Frame | CLPBY | Sector | S&P500 |
---|---|---|---|
1-Week Return | 1.08% | 2.25% | 1.09% |
1-Month Return | -3.29% | -0.67% | 3.49% |
3-Month Return | -8.14% | -5.58% | 7.84% |
6-Month Return | 4.46% | 4.13% | 14.42% |
1-Year Return | 6.91% | 13.67% | 32.47% |
3-Year Return | -22.36% | 11.4% | 29.54% |
5-Year Return | 6.91% | 48.17% | 91.74% |
10-Year Return | 44.99% | 112.28% | 193.25% |
Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 18.54B | 19.43B | 22.58B | 24.50B | 27.03B | [{"date":"2020-09-30","value":68.61,"profit":true},{"date":"2021-09-30","value":71.87,"profit":true},{"date":"2022-09-30","value":83.53,"profit":true},{"date":"2023-09-30","value":90.64,"profit":true},{"date":"2024-09-30","value":100,"profit":true}] |
Cost of Revenue | 5.93B | 6.11B | 7.05B | 8.17B | 8.76B | [{"date":"2020-09-30","value":67.71,"profit":true},{"date":"2021-09-30","value":69.78,"profit":true},{"date":"2022-09-30","value":80.47,"profit":true},{"date":"2023-09-30","value":93.28,"profit":true},{"date":"2024-09-30","value":100,"profit":true}] |
Gross Profit | 12.61B | 13.31B | 15.53B | 16.33B | 18.27B | [{"date":"2020-09-30","value":69.03,"profit":true},{"date":"2021-09-30","value":72.87,"profit":true},{"date":"2022-09-30","value":85,"profit":true},{"date":"2023-09-30","value":89.38,"profit":true},{"date":"2024-09-30","value":100,"profit":true}] |
Gross Margin | 68.01% | 68.53% | 68.78% | 66.64% | 67.59% | [{"date":"2020-09-30","value":98.89,"profit":true},{"date":"2021-09-30","value":99.64,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":96.9,"profit":true},{"date":"2024-09-30","value":98.27,"profit":true}] |
Operating Expenses | 6.76B | 6.96B | 8.62B | 9.56B | 10.95B | [{"date":"2020-09-30","value":61.72,"profit":true},{"date":"2021-09-30","value":63.55,"profit":true},{"date":"2022-09-30","value":78.72,"profit":true},{"date":"2023-09-30","value":87.29,"profit":true},{"date":"2024-09-30","value":100,"profit":true}] |
Operating Income | 5.85B | 6.36B | 6.44B | 6.77B | 7.32B | [{"date":"2020-09-30","value":79.97,"profit":true},{"date":"2021-09-30","value":86.82,"profit":true},{"date":"2022-09-30","value":87.96,"profit":true},{"date":"2023-09-30","value":92.5,"profit":true},{"date":"2024-09-30","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (438.00M) | (167.00M) | (536.00M) | (1.35B) | - | [{"date":"2020-09-30","value":-43800000000,"profit":false},{"date":"2021-09-30","value":-16700000000,"profit":false},{"date":"2022-09-30","value":-53600000000,"profit":false},{"date":"2023-09-30","value":-135000000000,"profit":false},{"date":"2024-09-30","value":"-","profit":true}] |
Pre-Tax Income | 5.47B | 6.23B | 6.13B | 6.03B | 6.39B | [{"date":"2020-09-30","value":85.47,"profit":true},{"date":"2021-09-30","value":97.47,"profit":true},{"date":"2022-09-30","value":95.81,"profit":true},{"date":"2023-09-30","value":94.21,"profit":true},{"date":"2024-09-30","value":100,"profit":true}] |
Income Taxes | 1.27B | 1.41B | 1.42B | 1.24B | 1.34B | [{"date":"2020-09-30","value":89.3,"profit":true},{"date":"2021-09-30","value":99.09,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":87.4,"profit":true},{"date":"2024-09-30","value":94.51,"profit":true}] |
Income After Taxes | 4.20B | 4.83B | 4.71B | 4.78B | - | [{"date":"2020-09-30","value":86.98,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":97.53,"profit":true},{"date":"2023-09-30","value":99.13,"profit":true},{"date":"2024-09-30","value":"-","profit":true}] |
Income From Continuous Operations | 4.20B | 4.83B | 4.71B | 4.78B | - | [{"date":"2020-09-30","value":86.98,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":97.53,"profit":true},{"date":"2023-09-30","value":99.13,"profit":true},{"date":"2024-09-30","value":"-","profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}] |
Net Income | 4.20B | 4.83B | 4.71B | 4.78B | 5.05B | [{"date":"2020-09-30","value":83.08,"profit":true},{"date":"2021-09-30","value":95.51,"profit":true},{"date":"2022-09-30","value":93.15,"profit":true},{"date":"2023-09-30","value":94.68,"profit":true},{"date":"2024-09-30","value":100,"profit":true}] |
EPS (Diluted) | 14.87 | 0.37 | 0.33 | 0.33 | 0.33 | [{"date":"2020-09-30","value":100,"profit":true},{"date":"2021-09-30","value":2.49,"profit":true},{"date":"2022-09-30","value":2.25,"profit":true},{"date":"2023-09-30","value":2.2,"profit":true},{"date":"2024-09-30","value":2.2,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
CLPBY | |
---|---|
Cash Ratio | 0.08 |
Current Ratio | 1.02 |
Quick Ratio | 0.66 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
CLPBY | |
---|---|
ROA (LTM) | 9.49% |
ROE (LTM) | 28.67% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
CLPBY | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.63 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.37 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
CLPBY | |
---|---|
Trailing PE | 40.38 |
Forward PE | 34.36 |
P/S (TTM) | 1.06 |
P/B | 11.51 |
Price/FCF | 19 |
EV/R | 8.37 |
EV/Ebitda | 26.69 |
PEG | 3.38 |
Coloplast A (CLPBY) share price today is $12.65
Yes, Indians can buy shares of Coloplast A (CLPBY) on Vested. To buy Coloplast A from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CLPBY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Coloplast A (CLPBY) via the Vested app. You can start investing in Coloplast A (CLPBY) with a minimum investment of $1.
You can invest in shares of Coloplast A (CLPBY) via Vested in three simple steps:
The 52-week high price of Coloplast A (CLPBY) is $14.22. The 52-week low price of Coloplast A (CLPBY) is $10.72.
The price-to-earnings (P/E) ratio of Coloplast A (CLPBY) is
The price-to-book (P/B) ratio of Coloplast A (CLPBY) is 11.51
The dividend yield of Coloplast A (CLPBY) is 2.45%
The market capitalization of Coloplast A (CLPBY) is
The stock symbol (or ticker) of Coloplast A is CLPBY